United Capital Financial Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,340
Closed -$231K 1104
2024
Q3
$231K Sell
2,340
-133
-5% -$13.1K ﹤0.01% 957
2024
Q2
$229K Buy
2,473
+60
+2% +$5.56K ﹤0.01% 933
2024
Q1
$229K Buy
2,413
+45
+2% +$4.27K ﹤0.01% 967
2023
Q4
$211K Sell
2,368
-1,462
-38% -$131K ﹤0.01% 986
2023
Q3
$280K Sell
3,830
-734
-16% -$53.6K ﹤0.01% 741
2023
Q2
$380K Sell
4,564
-10,621
-70% -$884K ﹤0.01% 725
2023
Q1
$1.16M Buy
15,185
+538
+4% +$41K 0.01% 542
2022
Q4
$1.22M Sell
14,647
-1,420
-9% -$118K 0.01% 572
2022
Q3
$1.27M Sell
16,067
-460
-3% -$36.5K 0.01% 562
2022
Q2
$1.23M Buy
16,527
+144
+0.9% +$10.7K 0.01% 592
2022
Q1
$1.47M Buy
16,383
+5,301
+48% +$476K 0.01% 587
2021
Q4
$1.24M Buy
11,082
+237
+2% +$26.5K 0.01% 633
2021
Q3
$1.36M Sell
10,845
-4
-0% -$503 0.01% 601
2021
Q2
$1.47M Buy
10,849
+140
+1% +$19K 0.01% 602
2021
Q1
$1.45M Buy
10,709
+103
+1% +$14K 0.01% 575
2020
Q4
$1.49M Buy
10,606
+608
+6% +$85.6K 0.01% 572
2020
Q3
$1.11M Buy
9,998
+549
+6% +$61.2K 0.01% 630
2020
Q2
$1.06M Buy
9,449
+296
+3% +$33.1K 0.01% 645
2020
Q1
$709K Buy
9,153
+856
+10% +$66.3K 0.01% 705
2019
Q4
$789K Buy
8,297
+353
+4% +$33.6K 0.01% 854
2019
Q3
$606K Buy
7,944
+4,541
+133% +$346K ﹤0.01% 884
2019
Q2
$299K Sell
3,403
-117
-3% -$10.3K ﹤0.01% 1197
2019
Q1
$319K Buy
3,520
+335
+11% +$30.4K ﹤0.01% 1089
2018
Q4
$229K Sell
3,185
-349
-10% -$25.1K ﹤0.01% 1158
2018
Q3
$339K Buy
3,534
+802
+29% +$76.9K ﹤0.01% 1064
2018
Q2
$260K Buy
2,732
+416
+18% +$39.6K ﹤0.01% 1140
2018
Q1
$203K Buy
+2,316
New +$203K ﹤0.01% 1232
2017
Q4
Sell
-2,306
Closed -$200K 1364
2017
Q3
$200K Buy
+2,306
New +$200K ﹤0.01% 1237
2016
Q1
Sell
-5,858
Closed -$411K 1285
2015
Q4
$411K Sell
5,858
-5,373
-48% -$377K ﹤0.01% 934
2015
Q3
$699K Sell
11,231
-101,395
-90% -$6.31M 0.01% 798
2015
Q2
$9.47M Buy
112,626
+98,310
+687% +$8.27M 0.11% 226
2015
Q1
$985K Buy
+14,316
New +$985K 0.01% 723